HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Warnings Slow, But Anti-Aging Claims Remain Class Action Targets

This article was originally published in The Rose Sheet

Executive Summary

The online universe is abuzz with complaints about 2016, with some ready to dub the year “worst ever.” It certainly was a rough one for anti-aging skin-care marketers, and while FDA’s warning letter activity has declined of late, consumer lawsuits continue to file challenging companies’ clock-reversing promises.


Related Content

Adore Settles With Nationwide Class Over Apple Stem Cell Anti-Aging Claims
2017 In Review: FDA's Cosmetics Slowdown Could Bolster Case For Legislative Jumpstart
Class Action Blight: The Sour Side Of Apple Stem Cell Anti-Aging Boom
Long Time Coming? Drinkable Sunscreen Maker Sued For Fraud
FDA Divulges Cosmetics Enforcement Data, Notes Hair Loss As ‘Serious’ AE
J&J Skin Care Continues Apace With ‘Rapid’ Products, ‘1 Week’ Claims
FDA Warning Cites Ageless Derma's Anti-Wrinkle, Brightening Claims
Avon Beats Class Bid In Suit Challenging Anti-Aging Claims; Appeal Filed
Supreme Court Turns Down Athena v. Allergan; 'Torrent' Of Suits To Come?
Mibelle Looks To Maintain Momentum In Plant Stem Cells


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts